In September, we added 116 citations in DIDB, including 51 in vitro (with 25 articles published in September 2025) and 65 in vivo articles (with 45 articles published in September 2025).
3 NDAs approved in September 2025, including Brensocatib (BRINSUPRI), Sebetralstat (EKTERLY), and Aceclidine (VIZZ) were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.